Priya Singhal - Sep 1, 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)

Signature
/s/ Wendell Taylor, attorney-in-fact for Priya Singhal
Stock symbol
BIIB
Transactions as of
Sep 1, 2023
Transactions value $
-$331,731
Form type
4
Date filed
9/6/2023, 06:06 PM
Previous filing
Jul 5, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +1.67K +57.04% $0.00 4.59K Sep 1, 2023 Direct
transaction BIIB Common Stock Tax liability -$216K -807 -17.57% $267.17 3.79K Sep 1, 2023 Direct
transaction BIIB Common Stock Sale -$116K -431 -11.39% $269.43 3.35K Sep 5, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -1.67K -33.33% $0.00 3.34K Sep 1, 2023 Common Stock 1.67K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This award was granted to the reporting person on September 1, 2022 and will vest in three equal installments on each anniversary of the grant date.